Research graph
References from The polycystic ovary syndrome: treatment with insulin sensitizing agents. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1210/jc.83.9.3078
10.1210/jc.83.9.3078 · External reference
10.1210/jcem-57-2-356
10.1210/jcem-57-2-356 · External reference
10.1210/jc.75.2.577
10.1210/jc.75.2.577 · External reference
Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome.
10.2337/diab.41.10.1257 · 1992 · External reference
a long‐term follow‐up focusing on natural history and circulating hormones.
1956 · External reference
10.1016/s0002-9343(99)80057-6
10.1016/s0002-9343(99)80057-6 · External reference
10.2337/diacare.22.1.141
10.2337/diacare.22.1.141 · External reference
10.1210/jc.84.1.165
10.1210/jc.84.1.165 · External reference
Role ofsulin resistance in human disease.
1988 · External reference
Insulin resistance, hyperinsulinemia, hypertriglyceridemia, and hypertension: Parallels between human disease and rodent models.
10.2337/diacare.14.3.195 · 1991 · External reference
10.1056/nejm198903163201105
10.1056/nejm198903163201105 · External reference
10.1016/0002-9343(83)90653-8
10.1016/0002-9343(83)90653-8 · External reference
10.2337/diab.37.3.262
10.2337/diab.37.3.262 · External reference
10.1172/jci114745
10.1172/jci114745 · External reference
10.1210/endo-123-2-733
10.1210/endo-123-2-733 · External reference
10.1172/jci106628
10.1172/jci106628 · External reference
10.1210/jcem-68-6-1027
10.1210/jcem-68-6-1027 · External reference
10.1016/0002-9378(90)90698-7
10.1016/0002-9378(90)90698-7 · External reference
10.1007/bf01263443
10.1007/bf01263443 · External reference
10.7326/0003-4819-83-4-567
10.7326/0003-4819-83-4-567 · External reference
10.1007/bf00562061
10.1007/bf00562061 · External reference
10.1111/j.1365-2125.1981.tb01206.x
10.1111/j.1365-2125.1981.tb01206.x · External reference
Metformin decreases the high plasminogen activator inhibition capacity, plasma insulin and triglyceride levels in non‐diabetic obese subjects.
10.1055/s-0038-1651126 · 1987 · External reference
10.1210/jcem-73-6-1294
10.1210/jcem-73-6-1294 · External reference
10.2337/diacare.10.1.62
10.2337/diacare.10.1.62 · External reference
10.2337/diabetes.32.12.1083
10.2337/diabetes.32.12.1083 · External reference
10.2337/diacare.13.1.1
10.2337/diacare.13.1.1 · External reference
10.1136/bmj.2.6102.1576
10.1136/bmj.2.6102.1576 · External reference
10.1016/0026-0495(85)90139-8
10.1016/0026-0495(85)90139-8 · External reference
Metformin reduces insulin requirement in type I diabetes.
1998 · External reference
10.1530/eje.0.1380269
10.1530/eje.0.1380269 · External reference
Inhibition of gluconeogenesis from lactate by phenethylbiguanide in the perfused guinea pig liver.
1982 · External reference
Inhibition of hepatic glucose output due to an inhibition of gluconeogenesis.
1982 · External reference
10.1016/0026-0495(94)90209-7
10.1016/0026-0495(94)90209-7 · External reference
10.1056/nejm199608293350902
10.1056/nejm199608293350902 · External reference
10.1210/jc.82.12.4075
10.1210/jc.82.12.4075 · External reference
10.1056/nejm199806253382603
10.1056/nejm199806253382603 · External reference
10.1016/s0029-7844(97)00296-2
10.1016/s0029-7844(97)00296-2 · External reference
10.1210/jc.80.7.2057
10.1210/jc.80.7.2057 · External reference
10.1016/s0015-0282(16)58266-1
10.1016/s0015-0282(16)58266-1 · External reference
10.1210/jc.82.2.524
10.1210/jc.82.2.524 · External reference
10.1111/j.1749-6632.1993.tb43860.x
10.1111/j.1749-6632.1993.tb43860.x · External reference
10.1055/s-2007-1009245
10.1055/s-2007-1009245 · External reference
10.1210/jcem-65-3-499
10.1210/jcem-65-3-499 · External reference
10.2337/diab.38.9.1165
10.2337/diab.38.9.1165 · External reference
10.1111/j.1365-2265.1993.tb02144.x
10.1111/j.1365-2265.1993.tb02144.x · External reference
10.1210/jc.81.8.2854
10.1210/jc.81.8.2854 · External reference
10.1016/s0015-0282(98)00011-9
10.1016/s0015-0282(98)00011-9 · External reference
10.1007/bf01221950
10.1007/bf01221950 · External reference
10.1046/j.1365-2796.1996.364690000.x
10.1046/j.1365-2796.1996.364690000.x · External reference
10.1016/s0002-9343(99)80056-4
10.1016/s0002-9343(99)80056-4 · External reference
10.1016/s0002-9378(11)90605-x
10.1016/s0002-9378(11)90605-x · External reference
10.3109/00016349209006227
10.3109/00016349209006227 · External reference
10.1046/j.1365-2796.1997.00236.x
10.1046/j.1365-2796.1997.00236.x · External reference
10.1016/s0026-0495(97)90066-4
10.1016/s0026-0495(97)90066-4 · External reference
10.1056/nejm199411033311803
10.1056/nejm199411033311803 · External reference
Insulin‐like activity of new antidiabetic agent CP68722 in 3T3‐L1 adipocytes.
10.2337/diab.39.11.1414 · 1990 · External reference
10.1210/en.133.1.352
10.1210/en.133.1.352 · External reference
Troglitazone enhances differentiation, basal glucose uptake, and Glut 1 protein levels in 3T3‐L1 adipocytes.
10.1210/endo.137.11.8895337 · 1998 · External reference
Thiazolidinediones in the treatment ofsulin resistance and type 2 diabetes.
10.2337/diab.45.12.1661 · 1996 · External reference
10.1210/jc.81.9.3299
10.1210/jc.81.9.3299 · External reference
10.1210/jc.82.7.2108
10.1210/jc.82.7.2108 · External reference
10.1016/s0015-0282(98)00454-3
10.1016/s0015-0282(98)00454-3 · External reference
Unresolved reference
1998 · External reference
Unresolved reference
External reference
10.1073/pnas.90.13.5924
10.1073/pnas.90.13.5924 · External reference
10.1056/nejm199008093230603
10.1056/nejm199008093230603 · External reference
Multiple pathways in insulin signalling: fitting the covalent and allosteric puzzle pieces together.
1994 · External reference
10.1056/nejm199904293401703
10.1056/nejm199904293401703 · External reference
